Mitochondrial Dysfunction in Parkinson’s Disease: Pathogenesis and Neuroprotection

Protter, D., Lang, C., & Cooper, A. A. (2012). αSynuclein and Mitochondrial Dysfunction: A Pathogenic Partnership in Parkinson's Disease?. Parkinson＇s Disease, 2012(), 649-660. https://doi.org/10.1155/2012/829207
Schapira, A. H. V., & Gegg, M. (2011). Mitochondrial Contribution to Parkinson’s Disease Pathogenesis. Parkinson＇s Disease, 2011(), 86-92. https://doi.org/10.4061/2011/159160
Keane, P. C., Kurzawa, M., Blain, P. G., & Morris, C. M. (2011). Mitochondrial Dysfunction in Parkinson’s Disease. Parkinson＇s Disease, 2011(), 682-699. https://doi.org/10.4061/2011/716871
楊佩寧（2020）。Parkinson’s disease: investigation of pathogenic mechanism and therapeutic strategy of neuroinflammation〔碩士論文，國立臺灣師範大學〕。華藝線上圖書館。https://doi.org/10.6345/NTNU202001600
Yang, R., Gao, G., Mao, Z., & Yang, Q. (2016). Chaperone-Mediated Autophagy and Mitochondrial Homeostasis in Parkinson's Disease. Parkinson＇s Disease, 2016(), 116-122. https://doi.org/10.1155/2016/2613401